HAYA Therapeutics

A轮

HAYA Therapeutics is a company that discovers and develops innovative tissue and cell-selective genomic medications for fibrotic diseases and serious health conditions associated with ageing, including cancer.The company is headquartered at the life sciences park Biopôle in Lausanne, Switzerland.In February 2022, the company announced that it had established a new laboratory space at JLABS@ San Diego, part of Johnson & Johnson Innovation's global network of life science incubators. The main headquarters and laboratory facilities would remain in Lausanne, Switzerland.In February 2022, the company announced that it had closed a USD 5 million seed extension led by Humboldt Fund, with participation from existing investors including Broadview Ventures, Apollo Health Ventures, BERNINA BioInvest, 4See Ventures, Chroder Adveq and Viva BioInnovator. The total amount raised for the seed round was approximately USD 25 million.In May 2021, the company announced the successful closing of its CHF 18

https://www.hayatx.com/

470305

基本信息

公司全称

HAYA Therapeutics SA
类型

基因组药物开发商
产业领域

医药研发/制造、化学&生物药
公司人数

15人以下
地址

Route de la Corniche 6 Epalinges LAUSANNE VAUD 1066; CH;
联系电话
邮箱

info@hayatx.com
成立时间

2017-01-01

投融资

2025-05-08

A轮

Sofinnova Partners

Earlybird Venture Capital

Eli Lilly

Athos

+ND Capital

Alexandria Venture Investments

LifeLink Ventures

Apollo Health Ventures

Longview Ventures

4See Ventures

Schroders Capital
2022-05-03

捐赠/众筹

Innosuisse
2022-05-03

捐赠/众筹/授予

Innosuisse
2022-02-09

种子轮

Humboldt Fund

Viva BioInnovator

Schroder Adveq

4See Ventures

Apollo Health Ventures

Broadview Ventures
2021-05-20

种子轮

Schroder Adveq

Viva BioInnovator

Broadview Ventures

4See Ventures
2021-05-20

种子轮

Broadview Ventures

Viva BioInnovator

Schroder Adveq

4See Ventures

Apollo Health Ventures
2020-01-01

种子轮

Broadview Ventures
2017-11-17

未公开

未透露
加载更多

HAYA Therapeutics

基本信息

投融资

相关投融资企业